Summary DNA from 251 primary tumours obtained from 123 male and 125 female Norwegian patients with colorectal carcinoma was analysed for the presence of K-ras point mutations at codons 12 and 13. Mutations were found in 99 (39%) of the samples. The frequency of K-ras mutations was significantly related to age and sex of the patients, and to the location of the tumours (overall: P = 0.008). K-ras mutations were much less frequent in colonic tumours from male than female patients at younger ages (<40 years, odds ratio <0.014).
Summary DNA from 251 primary tumours obtained from 123 male and 125 female Norwegian patients with colorectal carcinoma was analysed for the presence of K-ras point mutations at codons 12 and 13. Mutations were found in 99 (39%) of the samples. The frequency of K-ras mutations was significantly related to age and sex of the patients, and to the location of the tumours (overall: P = 0.008). K-ras mutations were much less frequent in colonic tumours from male than female patients at younger ages (<40 years, odds ratio <0.014).
The low frequency might indicate that a different, ras-indendent pathway to neoplasia is dominating in the colon of younger males. In contrast, older men had more mutations than older women (e.g. 90 years, odds ratio = 5.8). An inverse but less pronounced relationship was seen for rectal tumours. The type of mutation was found to be associated to sex of patient and location of tumour. G-+C transversions accounted for 35% of the mutations in rectal tumours from females, in contrast to only 2.5% in the rest of the material (P = 0.0005). This may indicate that there are specific carcinogens acting in this location.
Neoplastic transformation is believed to be the result of accumulation of genetic alterations in a single cell during the life of an individual. Tumour pathogenesis is increasingly understood in terms of damage to critical regulatory genes and the attendant deregulation of biochemical signalling pathways in the cancer cell. The number of genes found to be associated to different malignancies is growing rapidly. Single base substitutions are the genetic change most frequently found (Fearon & Vogelstein, 1990; Capella et al., 1991) . The ras oncogenes, together with the p53 tumour-suppressor gene, are the genes most consistently found to be mutated in colorectal cancer and a number of other malignancies (Fearon & Vogelstein, 1990; Scott & Quirke, 1993) . Single base substitutions in codons 12, 13 or 61 result in an amino acid alteration in the gene product (p21r'), activating the oncogenic potential of the ras genes. The mutated protein is believed to alter signal transduction pathways in a way that stimulates clonal expansion of the cell (Barbacid, 1987; Bos, 1989) .
In sporadic colon carcinomas, K-ras mutations have been reported to occur in 40-60% of the cases (Burmer et al., 1989 (Burmer et al., , 1991 Capella et al., 1991) , and ras mutation appears to be a relatively early event in the adenoma-carcinoma sequence (Fearon & Vogelstein, 1990; Hamilton, 1992) . Little is known about the cause and mechanism of activation of ras and other oncogenes in the pathogenesis of human cancers. In animal tumour model systems, specific carcinogens have been found to induce distinct mutation patterns in ras genes (Barbacid, 1988) , but activation of ras in human tumours has not been linked to any particular agents. Dietary factors, colonic bacteria and bile composition are, however, related to incidence of colorectal cancer (Reddy et al., 1992) , and it is thus believed that mutational events underlying these cancers are caused by stool components.
Stool composition is known to vary with age and sex, and to differ between different segments of the large bowel. We therefore investigated if frequency or type of K-ras mutations is related to any of these parameters. (Dukes, 1932; Turnbull et al., 1967) , the tumours were staged from A to D (Table I ). The location of the tumours is illustrated in Figure 1 . For comparisons between different anatomical segments, we divided samples obtained from the colon and the rectum into two separate groups. Rectum was defined as the distal 15 cm of the large bowel. Subsegments of the colon are also illustrated.
Materials and methods

Patients
DNA extraction and in vitro amplification Genomic DNA was extracted from fresh tumour cell suspensions (Meling et al., 1992 ) using standard methods (Kunckel et al., 1977 washing in TMAC (tetramethylammonium chloride) solution as specified in the probe kit protocol. The remaining SSOtemplate hybrids were identified by autoradiography at -70'C for 1-4h.
DNA from blood of healthy individuals was tested with the same procedure as the tumour samples and used as references when reading the results. Sample reading was performed visually. Cut-off was set at autoradiography signal equal to the strongest signal of the negative controls, and signals stronger than the negative controls were scored as positive. After autoradiography, the membranes were dehybridised, and hybridised sequentially to each of the 13 probes of the panel.
Statistical analysis
Logistic regression analysis (Hosmer, 1989) of mutations varies for the colon and rectum. For colonic tumours, young men have significantly fewer mutations than young women, but this difference disappears at higher ages. Rectal tumours show an inverse but less pronounced relationship. Stage of tumour (STG) did not contribute to this model.
Mutation spectrum of K-ras in colorectal carcinomas
The distribution of the specific nucleotide changes at codon 12 and 13 of the 100 mutations identified is shown in Figure  2 . The most frequent mutations were G-*A transitions (57/ 100) and G-*T transversions (34/100). Only nine G-*C transversions were observed. Mutations in position 2 of a codon occurred approximately three times more frequently than mutations in position 1 (76% vs 24%).
Separate logistic models were constructed for comparing distribution of each types of base substitution with the other mutations. Associations to other variables were only significant for the G-*C transversions: SEX (p = -2.054, s.e. = 1.129, P = 0.067), LOC (p = 2.805, s.e. = 1.097, P = 0.012); overall significance of model, X2 = 15.2, P = 0.0005 (2 d.f.). In Figure 1 it is illustrated how eight of the nine tumours containing G-*C transversions were localised to the rectum; seven of these were from female patients. This base substitution accounted for 35% of the mutations found in rectal tumours from females, in contrast to only 2.5% in the other tumours. G-*C transversions contributed to 27% of stage A tumours, and none was detected in Dukes' D tumours. STG was not included in the model because the change in the scaled deviance (P = 0.11) just exceeded the limit for inclusion.
G-*A transition in position 2 of codon 13, resulting in a Gly-*Asp substitution in p2l'rz, has been found to occur predominantly in colorectal carcinomas of older patients (Capella et al., 1991) . When analysing for the distribution of this mutation in our material we found no such association.
Discussion
In this study of 251 colorectal carcinomas, we found one or more ras mutations in 39% of the samples. Our results show that the frequency of carcinomas containing activated K-ras is dependent on age and sex of the patients as well as location of the tumours. We also found the pattern of base substitutions to be associated to age and sex of patient, and location of tumours. At the two extremes, no ras mutations were found in tumours located proximal to the descending colon of men younger than 70 years of age, whereas rare mutations such as G->C transversions were almost exclusively observed in tumours of the rectum of women.
The frequency of mutation-bearing tumours in this material is similar to other reports based on the same technique to identify K-ras mutations in codons 12 and 13 (Laurent-Puig et al., 1991; Bos et al., 1987) . The method detects DNA samples containing 10% or more of the mutated species (20% of heterozygous cells). More sensitive techniques based on sequencing the gene from carefully selected tumour tissue (Burmer et al., 1989 (Burmer et al., , 1991 indicate that the actual frequency of K-ras mutations in colorectal cancers is somewhat higher (50-60%). By only testing for mutations in codons 12 and 13 of K-ras, we failed to detect possible mutations in codon 61 of K-ras and codons 12, 13 and 61 of N-ras. These could account for as many as 14% of all ras mutations in colorectal cancer (Vogelstein et al., 1988 ). Thus we have probably underestimated the number of mutations in this material. In populations of both low and high incidence of colon cancer, the incidence of cancer of the caecum and ascending colon is, typically, 10-20% higher in women than in men (McMicheal & Potter, 1983 , 1985 . This incidence is in direct contrast to the incidence of cancer in the descending and sigmoid colon, for which the sex ratio (male-female) of cancer incidence with increasing age becomes progressively and substantially greater than unity. For rectal cancer, male and female rates are similar at younger ages, but male rates increasingly predominate at older ages (McMicheal & Potter, 1983) . In our material, we found frequency of ras mutations to differ significantly with respect to age and sex of patients, and location of tumour. This might indicate that there is an association between activation of K-ras and the differences in incidence of colorectal cancer described above.
The most striking observation was the generally low frequency of tumours with ras mutation in the colon of younger male patients, and even a complete absence of such tumours in the proximal colon among these patients (Figure 1) . It is therefore of interest that the incidence of cancer in the proximal colon is reported to be higher in women than in men at all ages. Our results indicate that this sex difference may be related to a low frequency of K-ras mutation-bearing tumours in male patients. The logistic model based on these data suggests that only at high ages (>80) does the frequency of mutation among men exceed that of women. The ras activation in (proximal) colonic tumours might therefore be promoted by intrinsic or environmental factors related to females.
Several lines of evidence strongly suggest that female sex hormones, via their effects on bile acid production, bowel transit time and, possibly, bacterial fermentation and production of volatile fatty acids, are related to colorectal car-cinogenesis. Alterations in the amount and composition of enterohepatically circulating bile acids are highly related to the risk of proximal colon cancer (McMicheal & Potter, 1983 , 1985 . The carcinogenic effects of the bile components, deoxycholic acid and lithocholic acid are therefore of special interest for possible induction of ras mutations in this location.
Our results are compatible with the observation that different combinations of genetic alterations may result in a malignant phenotype (Fearon & Vogelstein, 1990; Scott & Quirke, 1993; McLellan et al., 1993) . Thus, some pathways to colorectal cancer may require a mutation in the K-ras gene, while others may not. This is illustrated by the findings in one patient in whom material from four carcinomas, distributed through the large bowel, was available. While the two distal tumours contained different base substitutions, only one of the two proximal tumours had a detectable mutation. These carcinomas have probably developed by independent mutational events and by different pathways.
Our results suggest that the ras-independent pathway(s) dominates in colon cancer of younger men (Table II, Figure  1 ). In this context it is of interest that patients of both sexes with hereditary non-polyposis colorectal carcinomas (HNPCCs), develop tumours at an early age and preferentially in the proximal colon (Lynch et al., 1992) . A gene that is most likely responsible for these tumours has recently been localised to chromosome 2 (2pl5-16) . If this gene participates in a distinct ras-independent pathway, one would not expect to find ras mutations in colorectal cancers from HNPCC patients. However, the hypothesis is not supported by a recent report describing a 61% frequency of K-ras mutations in 18 tumours from HNPCC patients . This high frequency is compatible with the notion that the HNPCC gene may be an altered replication factor that would accelerate the accumulation of somatic mutations, thus promoting cancer at early ages.
Studies in the field of animal carcinogen-induced tumour model systems reveal distinct ras mutation patterns specific for each carcinogen (Barbacid, 1988) . The concentration of tumours containing G-*C transversions in the rectum of female patients might therefore be the result of one or more distinct carcinogens acting in this location. Bile composition shows little relation to cancer in the rectum, consistent with the fact that most bile acid is reabsorbed in the proximal colon. The relatively high frequency of this mutation in females might therefore be related to sex differences in faecal concentration and transit time. Both bowel transit time and prevalence of constipation have been reported to be substantially higher in females than in males (McMicheal & Potter, 1983; Lampe et al., 1993) . The G-*C transversions and also the generally higher frequency of K-ras mutations in women might thus be related to the time of contact with, and the concentration of, particular carcinogens.
The differences in the prevalence and pattern of K-ras mutations in relation to patient age and sex, and tumour location described here may constitute a starting point for identifying the agents causing such mutations.
